MARIA PAZ
GARCIA-PORTILLA GONZALEZ
Catedrática de Universidad
Leeds and York Partnership NHS Foundation Trust
Leeds, Reino UnidoPublicaciones en colaboración con investigadores/as de Leeds and York Partnership NHS Foundation Trust (8)
2020
-
Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use
Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529
2019
-
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia
Schizophrenia Bulletin, Vol. 45, Núm. 2, pp. 305-314
-
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436
2018
-
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807
-
Inverse association between negative symptoms and body mass index in chronic schizophrenia
Schizophrenia Research, Vol. 192, pp. 69-74
-
Obstetric Phenotypes in the Heterogeneity of Schizophrenia
Journal of Nervous and Mental Disease, Vol. 206, Núm. 11, pp. 882-886
2015
-
The negative syndrome of schizophrenia: Three -underlying components are better than two
Schizophrenia Research, Vol. 166, Núm. 1-3, pp. 115-118
2014
-
Spanish adaptation and validation of the Brief Negative Symptoms Scale
Comprehensive Psychiatry, Vol. 55, Núm. 7, pp. 1726-1729